DrugPatentWatch Database Preview

Litigation for ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

« Back to Dashboard

US Court Litigation for ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
5,905,082	Glaxo Group Ltd. v. Lupin Ltd.		2008-08-29	2011-11-04	35:271 Patent Infringement	District Court, D. Delaware	None
6,417,191			2011-06-29	2014-01-24	35:271 Patent Infringement	District Court, D. Delaware	Defendant
6,417,191			2011-06-29	2014-01-24	35:271 Patent Infringement	District Court, D. Delaware	Defendant
8,129,385	ViiV Healthcare Company v. Gilead Sciences, Inc.		2018-02-07		35:271 Patent Infringement	District Court, D. Delaware	Plaintiff
9,242,986	ViiV Healthcare Company v. Lupin Limited		2017-11-02		35:271 Patent Infringement	District Court, D. Delaware	Defendant

Patent Trial and Appeal Board Cases for ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
6,417,191	Apotex Corp.		2014-06-02	2014-06-02	ViiV Healthcare Co.	Inter partes review		2014-12-08	DAVID BARRY
6,417,191	Teva Pharmaceuticals USA, Inc.		2015-01-08	2015-01-08	ViiV Healthcare Co.	Inter partes review		2015-06-25	DAVID BARRY